凝血和血小板激活标记物的演变 经过跨导管边缘到边缘美特拉维修后的凝血和血小板激活标记物
Sandra Hadjadj1, Jonathan Beaudoin1, Frédéric Beaupré1
1Quebec Heart and Lung Institute, Laval University, Quebec, QC G1V 4G5, Canada.
Journal of clinical medicine
|February 13, 2025
概括
通过透气管边缘到边缘的美特拉修复 (TEER) 会急性激活凝血,但不会激活血小板标记. 短期抗凝疗可能在TEER后优于抗血小板治疗,需要进一步调查.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心血管研究研究心血管研究
背景情况:
- 目前的抗血栓治疗建议中缺乏强有力的证据,即通过透气管进行边缘到边缘的额叶修复 (TEER).
- 在TEER后的最佳抗血栓策略 (抗血小板治疗[APT]与抗凝治疗[ACT]) 尚未确定.
研究的目的:
- 为了研究TEER之后的凝血和血小板标记物的激活模式和时间.
- 评估不同抗血栓治疗对这些标记物的影响.
主要方法:
- 对46名接受TEER的患者进行前性研究.
- 测量凝血激活标记物 (前热血素片段1 + 2 [F1 + 2],热血素-抗热血素III [TAT]) 和血小板激活标记物 (可溶性P-Selectin,可溶性CD-40联体物[sCD40L]).
- 在基线,TEER后24小时,1个月和1年评估的标志物.
主要成果:
- 凝血标志物 (F1 + 2,TAT) 在TEER后24小时显著增加,在1个月后恢复到基线.
- 在不接受ACT的患者中,F1 + 2和TAT水平在1个月和1年内仍然较高,与接受ACT的患者相比.
- 血小板激活标志物 (sP-Selectin,sCD40L) 在TEER后没有显著变化,无论APT使用.
结论:
- 在不影响血小板激活的情况下,TEER诱导了急性凝血系统的激活.
- 在TEER后常规使用双重抗血小板疗法 (APT) 可能没有益处.
- 短期抗凝疗 (ACT) 可能是比APT更有效的TEER后的抗血栓策略,值得进一步研究.
相关概念视频
01:22Formation of the Platelet Plug
3.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.9K
01:16Clot Retraction and Fibrinolysis
3.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.5K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
4.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.9K
01:05Introduction to Hemostasis
5.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.1K